MedTrace Logo

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

NCT01457768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 570

Last updated 2018-05-04

No results posted yet for this study

Summary

This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.

Conditions

  • Hepatitis C, Chronic

Sponsors & Collaborators

Principal Investigators

  • Gilead Study Director · Gilead Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-19
Primary Completion
2018-04-09
Completion
2018-04-09

Countries

  • United States
  • Australia
  • Austria
  • Canada
  • Czechia
  • Estonia
  • France
  • Germany
  • Italy
  • Netherlands
  • New Zealand
  • Poland
  • Puerto Rico
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457768 on ClinicalTrials.gov